MGT Capital Investments Inc Watch

from SC 13D ~1 page Joint Filing Agreement

from S-3/A 39 pages Amended and Restated at the Market Offering Agreement August 7 , 2018

from S-3/A 39 pages At the Market Offering Agreement July 23, 2018

from S-3 39 pages At the Market Offering Agreement

from SC 13D/A 2 pages Transactions in the Shares — The Reporting Persons

from SC 13D 3 pages Transactions in the Shares — The Reporting Persons

from SC 13D/A ~1 page Schedule 13d/a Joint Filing Agreement

from 8-K 2 pages MGT Capital Investments, Inc.: Failure to Satisfy a Continued Listing Rule Based on a Lack of Shareholder Meeting in 2008 and Medicsight Statement Regarding Cms Proposed Decision

from 8-K 2 pages Medicsight Announces Appointment of Nm Rothschild & Sons Limited as Corporate Adviser Company Announces Appointment of Nomura Code Securities Limited as Nominated Adviser and Sole Broker

from 8-K 2 pages MGT Capital Investments, Inc. Is Delighted With the Announcement of Medicsight’s Commercial Agreement With Toshiba Pacs Division Medicsight and Toshiba Pacs Division Sign Commercial Agreement

from 8-K 2 pages MGT Capital Investments, Inc. Announces Subsidiary’s Preliminary Agreement to Acquire Maydeal.com

from 8-K 12 pages MGT Capital Investments, Inc. By-Laws Adopted by the Board of Directors on December 28, 2007

from 8-K ~5 pages Medicsight PLC (“Medicsight” or “The Company”) Third Quarter Summary Trading Statement

from 8-K 1 page “In Addition, I Believe That Our Medicsight Subsidiary Has Tremendous Potential for Future Growth. We Recently Announced the Positive Results of the Acrin Study, Endorsing the Use of Virtual Colonoscopy, and We Believe That as a Result of This Study, Medicsight’s Virtual Colonoscopy Technology Will See Increased Future Demand.” About MGT Capital Investments, Inc

from 8-K 14 pages Medicsight PLC (“Medicsight” or “The Company”) Interim Results for the Six Months Ended 30 June 2007

from 8-K 1 page MGT Chairman and CEO Buys $5 Million Worth of MGT Shares - Company to Ring AMEX Opening Bell on Monday, July 9, 2007

from 8-K 2 pages Dear Stockholder You May Well Have Seen Some Press Over the Last Two Weeks Relating to the Initial Public Offering (“Ipo”) of Our Subsidiary, Medicsight PLC on the London Stock Exchange’s Alternative Investment Market (“Aim”). the Reasons for the Medicsight PLC Floatation Were: 1. to Raise a Net $60m in Medicsight PLC - Which Means That Medicsight PLC Will Require No Further Funding From MGT; 2. to Use Part of the Ipo Proceeds to Repay the Final Piece of Debt (Approximately $11.5m) Back to MGT; 3. to Leave Sufficient Funds in Medicsight PLC for Working Capital and Business Development. I Am Delighted to Announce That the Ipo Was Completed on Schedule and Medicsight Plc’s Shares Were Listed on the Aim Exchange on June 21 Under the Ticker Symbol “Mdst”. Immediately Prior to the Ipo, MGT Sold Down 11.7m Medicsight PLC Shares in a Private Placement at £1.10, Yielding Net Cash Proceeds of $24m to MGT. This Left MGT With 85m Medicsight PLC Shares Which Will Have a Valuation of £1.10 to £3.50 on a 3 Year Target Range. These Actions Had the Benefit Of: A. Releasing Significant Cash for Future MGT Investments; B. Crystallising a Market Value for the Remaining 85m Medicsight Shares That We Hold; C. Reducing the MGT Holding in Medicsight to a 55% Controlling Stake. Post These Transactions, MGT Could Have a Current and Potential Net Asset Value as Follows: MGT Net Asset Values ($000) Jun 21 3 Year Target Cash and Equivalents $ 42,000 $ 42,000 Medicsight - 85m Shares (£1.10 to £3.50) $ 185,130 $ 589,050 Medicexchange - 22.5m Shares (£1.25 to £2.50) $ 55,600 $ 111,199 Net Asset Value $ 282,730 $ 742,249 Per Share (38.9m Shares) $ 7.27 $ 19.08

from 8-K 1 page Aim Ipo for MGT Subsidiary

from 8-K 1 page Certificate of Ownership and Merger Merging MGT Capital Investments, Inc. Into Medicsight, Inc

from 10KSB ~10 pages Agreement and Plan of Divestiture